Fagron SA

FAGR

Equity

ISIN BE0003874915 / Valor 3425437

Euronext - Euronext Brussels (2024-09-18)

EUR 18.80-0.74%

Fagron SA
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Fagron SA is a company that operates in a knowledge-intensive niche market, offering customized formulas for pharmacists and prescribers. The company's focus is on informing and training healthcare professionals about compounding through Fagron Academies in the countries where they operate. Fagron aims to improve personalized medicine and make it more accessible for patients, ultimately impacting the health and welfare of people.

Summarized from source with an LLMView SourceSector: Healthcare

Revenue Growth

Fagron SA reported a strong topline performance for the first half of 2024, with a 15.5% increase in reported revenue, reaching €429.3 million. This growth was driven by a 12.8% organic growth at constant exchange rates (CER), reflecting robust performances across all regions.

REBITDA Increase

The company achieved a 17.2% increase in REBITDA, amounting to €84.6 million for the first half of 2024. This improvement translated to a 30 basis points uplift in the REBITDA margin year-on-year, reaching 19.7%, which was attributed to synergies from acquisitions and operational excellence benefits globally.

Net Earnings Per Share

Fagron SA's net earnings per share saw a significant increase of 22.2% year-on-year, reaching €0.55 for the first half of 2024. This growth in earnings per share underscores the company's strong financial performance during the period.

Operating Cash Flow

Operating cash flow for Fagron SA decreased by 3.1% to €41.9 million in the first half of 2024. However, when adjusted for the factoring impact, the operating cash flow actually increased by 34.7%, indicating a strong underlying cash generation capability.

Upgraded Revenue Outlook

Fagron SA has upgraded its full-year 2024 revenue outlook to a range of €850 – €870 million, reiterating an expected improvement in profitability year-on-year. This optimistic outlook is supported by strategic investments and strong underlying demand for the company's services.

Summarized from source with an LLMView Source

Key figures

16.0%1Y

7.31%3Y

16.1%5Y

Performance

19.7%1Y

26.4%3Y

27.3%5Y

Volatility